|
|
Volumn 26, Issue 6, 2000, Pages 657-659
|
|
Antithrombin in severe sepsis - 'New' indication of an 'old' drug?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACTIVATED PROTEIN C;
ANTITHROMBIN;
BRADYKININ;
BRADYKININ ANTAGONIST;
CORTICOSTEROID;
INTERLEUKIN 1;
NONSTEROID ANTIINFLAMMATORY AGENT;
TESTIS DETERMINING FACTOR;
THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;
TISSUE FACTOR PATHWAY INHIBITOR;
TUMOR NECROSIS FACTOR ALPHA;
CLINICAL TRIAL;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG SAFETY;
EDITORIAL;
HUMAN;
PROTECTION;
PROTEIN BLOOD LEVEL;
SEPSIS;
SEPTIC SHOCK;
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;
|
|
EID: 0033937914
PISSN: 03424642
EISSN: None
Source Type: Journal
DOI: 10.1007/s001340051228 Document Type: Editorial |
|
Times cited : (6)
|
|
References (20)
|
